Objective
Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity DVT with the ClotTriever System
CLOUT Registry Interim Results (N=250)
ClotTriever System Outcomes in Lower Extremity DVT, including Sub-Analysis by Thrombus Chronicity
Lytic-free Mechanical Thrombectomy
Procedural Results



Significant Thrombus Removal Across DVT Chronicity

*≥75% thrombus removal determined by independent core laboratory-adjudicated Marder scores
Positive Safety Outcomes
At 30 Days*
Vessel / Valve Damage
0.0 %
Acute Renal Injury
0.0%
Device Related SAEs
0.4%
*Adjudicated by an independent medical monitor
Long-Term Patient Benefits
At 6 Months90.1%
Normal flow via duplex ultrasound100%
Median reduction in pain

Conclusions
Positive 6-month results of the first 250 patients enrolled in the multi-center, prospective, all-comer CLOUT registry show successful thrombus removal was achieved in 85.8% of patients in a single session without the use of thrombolytics. Effective thrombus removal led to significant improvements in duplex ultrasound assessments and clinical outcomes through 6 months for all DVT chronicity subgroups.